Anthrax Vaccines Market

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.

Anthrax Vaccines Market contains market size and forecasts of Anthrax Vaccines in global, including the following market information:

Global Anthrax Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Anthrax Vaccines Market Sales, 2017-2022, 2023-2028, (M Doses)

Global top five Anthrax Vaccines companies in 2021 (%)

The global Anthrax Vaccines market was valued at 674 million in 2021 and is projected to reach US$ 1101.7 million by 2028, at a CAGR of 7.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Live Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Anthrax Vaccines include Emergent BioSolutions, Merial, Merck, Zoetis, Bayer Sanidad Animal, Colorado Serum, PharmAthene, Tiankang and Biog?nesis-Bago, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anthrax Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anthrax Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Anthrax Vaccines Market Segment Percentages, by Type, 2021 (%)

Live Vaccines

Cell free PA Vaccines

Global Anthrax Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Anthrax Vaccines Market Segment Percentages, by Application, 2021 (%)

Human Use

Animal Use

Global Anthrax Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Anthrax Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anthrax Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Anthrax Vaccines revenues share in global market, 2021 (%)

Key companies Anthrax Vaccines sales in global market, 2017-2022 (Estimated), (M Doses)

Key companies Anthrax Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Emergent BioSolutions

Merial

Merck

Zoetis

Bayer Sanidad Animal

Colorado Serum

PharmAthene

Tiankang

Biog?nesis-Bago

CAVAC

Rosenbusch

Agrovet

Vecol

CVCRI

IVPM

Prondil

CDV

Indian Immunologicals

Botswana Vaccine Institute

Ceva Sant? Animale

Intervac

JOVAC